Tissue Factor in Hemostasis and Thrombosis

ABSTRACT

Tissue factor (TF) plays an essential role in hemostasis. The tissue-specific pattern of TF expression is consistent with additional hemostatic protection in vital organs. An aberrant expression of TF within the vasculature occurs in a variety of diseases, including atherosclerosis, cancer, and sepsis. TF expression in these diseases is associated with thrombotic events. Future therapeutic strategies may prove beneficial in the treatment of thrombosis. However, these strategies should be designed to avoid compromising hemostasis.

KEYWORDS

Tissue factor - hemostasis - thrombosis - procoagulant - anticoagulant

REFERENCES

• 1 Drake T A, Morrissey J H, Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.  Am J Pathol. 1989;  134 1087-1097
• 2 Fleck R A, Rao L V, Rapaport S I, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.  Thromb Res. 1990;  59 421-437
• 3 Eddleston M, de la Torre J C, Oldstone M B, Loskutoff D J, Edgington T S, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis.  J Clin Invest. 1993;  92 349-358
• 4 Erlich J, Parry G C, Fearns C et al.. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.  Proc Natl Acad Sci USA. 1999;  96 8138-8143
• 5 Pawlinski R, Fernandes A, Kehrle B et al.. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.  Proc Natl Acad Sci USA. 2002;  99 15333-15338
• 6 Luther T, Flossel C, Mackman N et al.. Tissue factor expression during human and mouse development.  Am J Pathol. 1996;  149 101-113
• 7 Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development.  Arterioscler Thromb Vasc Biol. 2004;  24 1015-1022
• 8 Parry G C, Erlich J H, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice.  J Clin Invest. 1998;  101 560-569
• 9 Pawlinski R, Pedersen B, Erlich J, Mackman N. Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice.  Thromb Haemost. 2004;  92 444-450
• 10 Lockwood C J, Runic R, Wan L, Krikun G, Demopolous R, Schatz F. The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception.  Hum Reprod. 2000;  15(suppl 3) 144-151
• 11 Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.  Blood. 2005;  105 2777-2782
• 12 Huang Z F, Higuchi D, Lasky N, Broze Jr G J. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.  Blood. 1997;  90 944-951
• 13 Day S M, Reeve J L, Pedersen B et al.. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.  Blood. 2005;  105 192-198
• 14 Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.  Blood. 2004;  104 3190-3197
• 15 Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.  Crit Care Med. 2004;  32 S293-S297
• 16 Rao L V. Tissue factor as a tumor procoagulant.  Cancer Metastasis Rev. 1992;  11 249-266
• 17 Tremoli E, Camera M, Toschi V, Colli S. Tissue factor in atherosclerosis.  Atherosclerosis. 1999;  144 273-283
• 18 Wilcox J N, Smith K M, Schwartz S M, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.  Proc Natl Acad Sci USA. 1989;  86 2839-2843
• 19 Annex B H, Denning S M, Channon K M et al.. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes.  Circulation. 1995;  91 619-622
• 20 Badimon J J, Lettino M, Toschi V et al.. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.  Circulation. 1999;  99 1780-1787
• 21 Callander N S, Varki N, Rao L V. Immunohistochemical identification of tissue factor in solid tumors.  Cancer. 1992;  70 1194-1201
• 22 Contrino J, Hair G, Kreutzer D L, Rickles F R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease.  Nat Med. 1996;  2 209-215
• 23 De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms.  Crit Rev Oncol Hematol. 2004;  50 187-196
• 24 Falanga A, Ofosu F A, Cortelazzo S et al.. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery.  Br J Haematol. 1993;  85 745-750
• 25 Langer F, Amirkhosravi A, Loges S et al.. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.  Thromb Haemost. 2004;  92 1136-1146
• 26 Verso M, Agnelli G, Bertoglio S et al.. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.  J Clin Oncol. 2005;  23 4057-4062
• 27 Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency.  Semin Fetal Neonatal Med. 2004;  9 357-369
• 28 Brenner B. Thrombophilia and fetal loss.  Semin Thromb Hemost. 2003;  29 165-170
• 29 Di Paolo S, Volpe P, Grandaliano G et al.. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction.  J Nephrol. 2003;  16 650-657
• 30 Tong M H, Jiang H, Liu P, Lawson J A, Brass L F, Song W C. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice.  Nat Med. 2005;  11 153-159
• 31 Parrillo J E. Pathogenetic mechanisms of septic shock.  N Engl J Med. 1993;  328 1471-1477
• 32 Levi M, Ten Cate H. Disseminated intravascular coagulation.  N Engl J Med. 1999;  341 586-592
• 33 Drake T A, Cheng J, Chang A, Taylor Jr F B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.  Am J Pathol. 1993;  142 1458-1470
• 34 Erlich J, Fearns C, Mathison J, Ulevitch R J, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits.  Infect Immunol. 1999;  67 2540-2546
• 35 Mackman N, Sawdey M S, Keeton M R, Loskutoff D J. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide.  Am J Pathol. 1993;  143 76-84
• 36 Aras O, Shet A, Bach R R et al.. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.  Blood. 2004;  103 4545-4553
• 37 Creasey A A, Chang A C, Feigen L, Wun T C, Taylor Jr F B, Hinshaw L B. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.  J Clin Invest. 1993;  91 2850-2860
• 38 Taylor Jr F B, Chang A, Ruf W et al.. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.  Circ Shock. 1991;  33 127-134
• 39 Taylor F B, Chang A C, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli .  Blood. 1998;  91 1609-1615
• 40 Pawlinski R, Pedersen B, Schabbauer G et al.. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.  Blood. 2004;  103 1342-1347